172 related articles for article (PubMed ID: 11128051)
1. Effect of the COX-2 selective inhibitor l-745,337 on inflammation and organ prostaglandin E2 (PGE2) levels in adjuvant arthritic rats.
Turull N; Queralt J
Inflammation; 2000 Dec; 24(6):533-45. PubMed ID: 11128051
[TBL] [Abstract][Full Text] [Related]
2. Changes in prostaglandin E2 (PGE2) levels in paw exudate, stomach and kidney of arthritic rats: effects of flosulide.
Turull A; Queralt J
Prostaglandins Other Lipid Mediat; 2001 Aug; 66(1):27-37. PubMed ID: 11519792
[TBL] [Abstract][Full Text] [Related]
3. The anti-inflammatory effect of FR188582, a highly selective inhibitor of cyclooxygenase-2, with an ulcerogenic sparing effect in rats.
Ochi T; Yamane-Sugiyama A; Ohkubo Y; Sakane K; Tanaka H
Jpn J Pharmacol; 2001 Feb; 85(2):175-82. PubMed ID: 11286400
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
5. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory activity of a novel selective cyclooxygenase-2 inhibitor, FR140423, on type II collagen-induced arthritis in Lewis rats.
Ochi T; Goto T
Prostaglandins Other Lipid Mediat; 2001 Dec; 66(4):317-27. PubMed ID: 11785783
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
[TBL] [Abstract][Full Text] [Related]
8. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
9. Selective cyclooxygenase-2 (COX-2) inhibitors reduce anti-Mycobacterium antibodies in adjuvant arthritic rats.
Turull A; Queralt J
Immunopharmacology; 2000 Jan; 46(1):71-7. PubMed ID: 10665781
[TBL] [Abstract][Full Text] [Related]
10. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
Ukawa H; Yamakuni H; Kato S; Takeuchi K
Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.
Tanaka A; Araki H; Hase S; Komoike Y; Takeuchi K
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():90-101. PubMed ID: 11966529
[TBL] [Abstract][Full Text] [Related]
12. Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.
Chan CC; Rodger IW
Adv Exp Med Biol; 1997; 407():157-61. PubMed ID: 9321947
[No Abstract] [Full Text] [Related]
13. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.
Chan CC; Boyce S; Brideau C; Ford-Hutchinson AW; Gordon R; Guay D; Hill RG; Li CS; Mancini J; Penneton M
J Pharmacol Exp Ther; 1995 Sep; 274(3):1531-7. PubMed ID: 7562530
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
16. The roles of nitric oxide and prostaglandins in alterations of ulcerogenic and healing responses in adjuvant-induced arthritic rat stomachs.
Kato S; Tanaka A; Kunikata T; Mizoguchi H; Takeuchi K
Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():18-25. PubMed ID: 10807399
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory activity of myricetin-3-O-beta-D-glucuronide and related compounds.
Hiermann A; Schramm HW; Laufer S
Inflamm Res; 1998 Nov; 47(11):421-7. PubMed ID: 9865500
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4'-isomer.
Pairet M; van Ryn J; Schierok H; Mauz A; Trummlitz G; Engelhardt G
Inflamm Res; 1998 Jun; 47(6):270-6. PubMed ID: 9683035
[TBL] [Abstract][Full Text] [Related]
19. Role of COX-2 inhibition on the formation and healing of gastric ulcers induced by indomethacin in the rat.
Godessart N; Salcedo C; Fernández AG; Palacios JM
Adv Exp Med Biol; 1999; 469():157-63. PubMed ID: 10667325
[No Abstract] [Full Text] [Related]
20. Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation.
Egan CG; Lockhart JC; Ferrell WR
J Physiol; 2004 Jun; 557(Pt 2):635-43. PubMed ID: 15064324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
